SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Micrologix biotech
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: checkmate who wrote (597)11/9/1999 12:07:00 PM
From: Sean Janzen  Read Replies (1) of 792
 
The odds are definitely against MBI. Somewhere in the order of 2% of penny stocks survive.

It probably wouldn't hurt to give MBI time. They have $14 Million in the bank. We know there will be news coming in the Spring. MBI needs to get the price above $4.00 for 60 days in mid 2000 to access an additional $9 million from the warrants of the recent financing.

What we are seeing is probably tax loss selling as expressed by an observer of Inflazyme Pharmaceuticals: "Tax Time"

stockhouse.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News